(Q33977266)

30 July 2017

1 reference

title

The role of bacterial infections in asthma (English)

1 reference

30 July 2017

0 references

Kraft M

1 reference

30 July 2017

publication date

1 June 2000

1 reference

Clinics in Chest Medicine

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

301-313

1 reference

Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Dexamethasone and oxytetracycline reverse the potentiation of neurogenic inflammation in airways of rats with Mycoplasma pulmonis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Chlamydia pneumoniae and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Chronic Chlamydia pneumoniae infection and asthma exacerbations in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

The association of Chlamydia pneumoniae infection and reactive airway disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Asthma and bacterial sinusitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Chlamydia pneumoniae and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Evidence for Chlamydia pneumoniae Infection in Steroid-Dependent Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Methyl prednisolone acetate modulation of infection and subsequent pulmonary pathology in hamsters exposed to parainfluenza-1 virus (Sendai).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Progressive bronchial obstruction during the acute stage of respiratory tract infection in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

The stability of peripheral airways

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Experience with newer techniques for the laboratory detection of Mycoplasma pneumoniae infection: Adelaide, 1978-1992

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Reversible airflow limitation in adults with respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Chlamydia pneumoniae and exacerbations of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Mycoplasma pneuminia infection. A follow-up study of 50 children with respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

The seroepidemiology of Chlamydiae in Finland over the period 1971 to 1987

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Branhamella catarrhalis colonization in preschool asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Management of sinusitis in the asthmatic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Asthma, atopy and Chlamydia pneumoniae antibodies in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970268-9

7 January 2021

10.1016/S0272-5231(05)70268-9

Identifiers

DOI

1 reference

30 July 2017

1 reference